Search research articles
Contact Us
Filters
Showing results (21-30 of 287) with videos related to
Page
of 29
Sort By:
Tumori
|
June 30, 1993
Prevention by L-carnitine of interleukin-2 related cardiac toxicity during cancer immunotherapy
P Lissoni, M A Galli, G Tancini, et al.
Anticancer Research
|
April 13, 2001
A phase II study of subcutaneous low-dose interleukin-2 plus erythropoietin in metastatic renal cell carcinoma progressing on interleukin-2 alone
P Lissoni, F Rovelli, N Baiocco, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
March 24, 1999
Transient increase of plasma interleukin-6 after infusion of recombinant tumor necrosis factor alpha in advanced cancer patients
B Zubelewicz, W Romanowski, B Braczkowska, et al.
Annals of the New York Academy of Sciences
|
September 30, 1995
Modulation of tumor necrosis factor-alpha (TNF-alpha) toxicity by the pineal hormone melatonin (MLT) in metastatic solid tumor patients
R Braczkowski, B Zubelewicz, W Romanowski, et al.
Tumori
|
November 1, 1995
Endocrine effects of granulocyte colony-stimulating factor in cancer patients
F Rovelli, S Barni, G Tancini, et al.
Tumori
|
June 30, 1988
Endocrine and clinical effects of an LHRH analogue in pretreated advanced breast cancer
P Lissoni, S Barni, S Crispino, et al.
Haematologica
|
September 1, 1991
Thrombocytosis, neutrophilia and anemia during interleukin-2 therapy
F Rossini, F Brivio, S Mingozzi, et al.
Journal of Endocrinological Investigation
|
February 1, 1990
A study of pineal-prolactin interaction: prolactin response to an acute melatonin injection in patients with hyperprolactinemia
P Lissoni, E Mainini, C Mazzi, et al.
Tumori
|
December 31, 1993
Subcutaneous therapy with low-dose interleukin-2 plus the neurohormone melatonin in metastatic gastric cancer patients with low performance status
P Lissoni, F Brivio, A Ardizzoia, et al.
The International Journal of Biological Markers
|
October 1, 1988
Soluble interleukin-2 receptor levels in Hodgkin's disease: preliminary considerations about their prognostic significance
P Lissoni, S Barni, F Rovelli, et al.
Page
of 29
Search research articles
Search
Showing results (21-30 of 287) with videos related to
Sort By:
Page
of 29
Tumori
|
June 30, 1993
Prevention by L-carnitine of interleukin-2 related cardiac toxicity during cancer immunotherapy
P Lissoni, M A Galli, G Tancini, et al.
Anticancer Research
|
April 13, 2001
A phase II study of subcutaneous low-dose interleukin-2 plus erythropoietin in metastatic renal cell carcinoma progressing on interleukin-2 alone
P Lissoni, F Rovelli, N Baiocco, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
March 24, 1999
Transient increase of plasma interleukin-6 after infusion of recombinant tumor necrosis factor alpha in advanced cancer patients
B Zubelewicz, W Romanowski, B Braczkowska, et al.
Annals of the New York Academy of Sciences
|
September 30, 1995
Modulation of tumor necrosis factor-alpha (TNF-alpha) toxicity by the pineal hormone melatonin (MLT) in metastatic solid tumor patients
R Braczkowski, B Zubelewicz, W Romanowski, et al.
Tumori
|
November 1, 1995
Endocrine effects of granulocyte colony-stimulating factor in cancer patients
F Rovelli, S Barni, G Tancini, et al.
Tumori
|
June 30, 1988
Endocrine and clinical effects of an LHRH analogue in pretreated advanced breast cancer
P Lissoni, S Barni, S Crispino, et al.
Haematologica
|
September 1, 1991
Thrombocytosis, neutrophilia and anemia during interleukin-2 therapy
F Rossini, F Brivio, S Mingozzi, et al.
Journal of Endocrinological Investigation
|
February 1, 1990
A study of pineal-prolactin interaction: prolactin response to an acute melatonin injection in patients with hyperprolactinemia
P Lissoni, E Mainini, C Mazzi, et al.
Tumori
|
December 31, 1993
Subcutaneous therapy with low-dose interleukin-2 plus the neurohormone melatonin in metastatic gastric cancer patients with low performance status
P Lissoni, F Brivio, A Ardizzoia, et al.
The International Journal of Biological Markers
|
October 1, 1988
Soluble interleukin-2 receptor levels in Hodgkin's disease: preliminary considerations about their prognostic significance
P Lissoni, S Barni, F Rovelli, et al.
Page
of 29